SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-041277
Filing Date
2016-11-07
Accepted
2016-11-07 16:37:49
Documents
64
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q prog20160707_10q.htm 10-Q 1267762
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 16000
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 16126
4 EXHIBIT 32 ex32.htm EX-32 8624
  Complete submission text file 0001437749-16-041277.txt   5444069

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS pgnx-20160930.xml EX-101.INS 1183165
6 EXHIBIT 101.SCH pgnx-20160930.xsd EX-101.SCH 48865
7 EXHIBIT 101.CAL pgnx-20160930_cal.xml EX-101.CAL 31823
8 EXHIBIT 101.DEF pgnx-20160930_def.xml EX-101.DEF 310884
9 EXHIBIT 101.LAB pgnx-20160930_lab.xml EX-101.LAB 276907
10 EXHIBIT 101.PRE pgnx-20160930_pre.xml EX-101.PRE 338849
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9147892800
PROGENICS PHARMACEUTICALS INC (Filer) CIK: 0000835887 (see all company filings)

IRS No.: 133379479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23143 | Film No.: 161978631
SIC: 2834 Pharmaceutical Preparations